Detalhe da pesquisa
1.
Pharmacological Activation of Nrf2 Enhances Functional Liver Regeneration.
Hepatology
; 74(2): 973-986, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872408
2.
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study.
Diagn Progn Res
; 7(1): 18, 2023 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37697410
3.
Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5.
Oncotarget
; 11(31): 3025, 2020 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32821347
4.
Increased expression of Id family proteins in small cell lung cancer and its prognostic significance.
Clin Cancer Res
; 14(8): 2318-25, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18413820
5.
Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppression.
Int J Oncol
; 32(4): 767-75, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18360704
6.
Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer.
Hum Pathol
; 38(9): 1321-9, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17599389
7.
Real-time in vivo imaging reveals localised Nrf2 stress responses associated with direct and metabolism-dependent drug toxicity.
Sci Rep
; 7(1): 16084, 2017 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29167567
8.
Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5.
Oncotarget
; 8(19): 31041-31056, 2017 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28415688
9.
The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance.
Oncotarget
; 7(50): 82783-82797, 2016 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27779102
10.
Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter.
Oncotarget
; 7(8): 9322-39, 2016 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26814431
11.
Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer.
Genes Cancer
; 5(5-6): 212-25, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25061504
12.
The expression of C-FABP and PPARγ and their prognostic significance in prostate cancer.
Int J Oncol
; 44(1): 265-75, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24189640
13.
A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells.
Genes Cancer
; 4(7-8): 297-314, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24167657
14.
Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expression.
Int J Oncol
; 38(4): 1083-91, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21290088
15.
Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expression.
Int J Oncol
; 37(3): 595-603, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20664928
16.
Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental therapy for prostate cancer in mouse xenografts.
Int J Oncol
; 36(1): 69-76, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19956834
17.
Prognostic significance of osteopontin expression in human prostate cancer.
Int J Cancer
; 118(9): 2255-61, 2006 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16331611